P2RY12 and myeloid sarcoma: In MS, modulated expression of P2Y12, P2X4 and P2X7 receptors stimulates the release of proinflammatory chemokines and cytokines as well as immune cell migration and proliferation that leads to demyelination and axonal damage (Domercq et al., 2019).